The deal size was increased to $275M from $175M and priced below last closing price of $13.02. Jefferies, TD Cowen, Goldman Sachs, Guggenheim and Raymond James are acting as joint book running managers for the offering.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RLAY:
- Relay Therapeutics price target raised to $21 from $19 at Citizens
- Relay Therapeutics price target raised to $27 from $21 at Barclays
- Relay Therapeutics announces $175M common stock offering
- Relay Therapeutics upgraded at JonesResearch after zovegalisib data
- Relay Therapeutics upgraded to Buy from Hold at JonesResearch